Akses terbuka Jurnal SINTA 1
Lifestyle Modifications and Nutraceutical Interventions in the Prevention and Management of Metabolic Syndrome
The Indonesian Biomedical Journal · Vol. 17 No. 3 (2025) · hlm. 207–232
- ISSN
- 2085-3297, 2355-9179
- Terbit
- 2025-06-17
- Penerbit
- Secretariat of The Indonesian Biomedical Journal
- Bahasa
- en
Abstrak
Abdominal obesity, dyslipidemia, hypertension, and hyperglycemia are metabolic risk factors that are grouped together to define metabolic syndrome (MetS). It is now widely recognized that MetS is linked to a higher risk of type 2 diabetes (T2DM) and cardiovascular disease (CVD). Overall, the pathophysiology of MetS initiated by the imbalance of nutrition intake and physical activity. It involves a complex interplay of insulin resistance (IR), inflammation, dysregulated adipocyte function, and genetic susceptibility, all of which contribute to the metabolic dysfunction. Lifestyle modifications play a crucial role in managing and preventing MetS. Key strategies include adopting a balanced diet like Mediterranean diet, Dietary Approaches to Stop Hypertension (DASH), or caloric restriction (CR), engaging in regular physical activity, and maintaining a healthy weight. Nutraceuticals, including polyphenols and CR-mimetic agents, improve insulin sensitivity, reduce inflammation, lower blood pressure and cholesterol levels, reducing oxidative stress, and promoting autophagy. In addition to lifestyle changes, drug therapy may be necessary for some individuals to manage specific risk factors, such as diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARB), calcium channel blockers, and beta blockers for hypertension; biguanides, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide 1(GLP-1) receptor agonists, sodium-glucose co-transporter 2 (SGLT2) inhibitors, and thiazolidinediones for hyperglycemia; and statins for dyslipidemia. Early diagnosis, including waist circumference and blood pressure measurement, serum cholesterol and glucose testing, and intervention, is essential to effectively manage MetS and prevent the progression of associated diseases. In conclusion, understanding the risk factors and associated risks of MetS, along with the implementation of lifestyle modifications such as dietary and nutraceutical interventions including polyphenols and CR-mimetic agents, is vital for reducing the burden of this syndrome. Early diagnosis and proactive management are key to improving long-term health outcomes.KEYWORDS: metabolic syndrome, abdominal obesity, insulin resistance, diet, nutraceuticals
Kata kunci
- metabolic syndrome
- lifestyle modification
- nutraceuticals
- polyphenols
- caloric restriction mimetics
- insulin resistance
- abdominal obesity
- dyslipidemia
- hypertension
- hyperglycemia
- Mediterranean diet
- DASH diet
- physical activity
- type 2 diabetes
- cardiovascular disease
- anti-inflammatory activity
- autophagy
- oxidative stress
- antihypertensive drugs
- antidiabetic drugs
- statins
- early diagnosis
Jaringan kolaborasi para penulis
40 penulis · 145 tautan kepenulisan bersama · 70 lintas organisasi · menampilkan 40 yang paling banyak terhubung
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Hasanuddin University
- Padjadjaran University
- PT Prodia StemCell Indonesia (Indonesia)
- Universitas Trisakti
- Udayana University
- University of Indonesia
- Universitas Airlangga
- Organisasi lain
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Suryani As’ád | Hasanuddin University | 15 |
| Gatot Susilo Lawrence | Hasanuddin University | 7 |
| Ferry Sandra | Universitas Trisakti | 7 |
| Yani Lina | Hasanuddin University | 6 |
| Ilhamjaya Patellongi | Hasanuddin University | 6 |
| Irma Ruslina Defi | Padjadjaran University | 6 |
| Cynthia Retna Sartika | PT Prodia StemCell Indonesia (Indonesia) | 5 |
| Anwar Santoso | Udayana University | 4 |
| Syakib Bakri | Hasanuddin University | 4 |
| Melisa Intan Barliana | Padjadjaran University | 4 |
| Keri Lestari | Padjadjaran University | 4 |
| Teguh Ranakusuma | University of Indonesia | 3 |
| Irawan Yusuf | Hasanuddin University | 3 |
| Rima Haifa | PT Prodia StemCell Indonesia (Indonesia) | 3 |
| Trilis Yulianti | Hasanuddin University | 3 |
| Irma Rahayu Latarissa | Padjadjaran University | 3 |
| Ida Paulina Sormin | Hasanuddin University | 3 |
| Erizal Sugiono | Hasanuddin University | 3 |
| Keri Lestari Dandan | Padjadjaran University | 3 |
| Lucia Herminawati | Hasanuddin University | 3 |
| Aziiz Mardanarian Rosdianto | Padjadjaran University | 3 |
| Rina Triana | Padjadjaran University | 3 |
| Yenny Surjawan | Hasanuddin University | 2 |
| Mansyur Arief | Hasanuddin University | 2 |
| Andri Hidayat | Hasanuddin University | 2 |
| Ahmad Faried | Padjadjaran University | 2 |
| Marsetio Donosepoetro | Universitas Airlangga | 2 |
| Burhanuddin Bahar | Hasanuddin University | 2 |
| Widjaja Lukito | SEAMEO Regional Center for Food and Nutrition | 2 |
| Indriyanti Rafi Sukmawati | Hasanuddin University | 2 |
| Antonia Anna Lukito | Hasanuddin University | 2 |
| Mansyur Arif | Hasanuddin University | 2 |
| Anna Meilana | Padjadjaran University | 2 |
| Made Putra Semadhi | Padjadjaran University | 2 |
| Candra Ninghayu | Hasanuddin University | 1 |
| Cissy Bana Kartasasmita | Padjadjaran University | 1 |
| Irmansyah Irmansyah | National Research and Innovation Agency | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.